Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-5004.91%Return on Invested Capital
VS
Market
Sector
Industry
History
$ 2.54Close
$ 1.18 - $ 11.68 52-Week Range
Ticker Information
Ticker
BTAICompany Name
BIOXCEL THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQBIOXCEL THERAPEUTICS INC - Return on Invested Capital Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
BTAI - ROIC Historical data
| Date | Invested Capital | Net Income Common Stock | Return on Invested Capital |
|---|---|---|---|
| 6/30/2025 | $ 1.02M | $ -50.95M | -5004.91% |
| 3/31/2025 | $ 15.35M | $ -40.06M | -260.92% |
| 12/31/2024 | $ 9.47M | $ -59.6M | -629.21% |
| 9/30/2024 | $ 18.97M | $ -71M | -374.29% |
| 6/30/2024 | $ 28.96M | $ -107.83M | -372.34% |
| 3/31/2024 | $ 29.62M | $ -153.05M | -516.7% |
| 12/31/2023 | $ 44.53M | $ -179.05M | -402.1% |
| 9/30/2023 | $ 59.01M | $ -211.6M | -358.57% |
| 6/30/2023 | $ 103.33M | $ -202.92M | -196.39% |
| 3/31/2023 | $ 148.77M | $ -187.08M | -125.75% |
Key Performance Insights, Last 5 Years
- BIOXCEL THERAPEUTICS INC's latest trailing twelve months (TTM) ROIC stands at -31.19%.
- Over the past 5 years, BIOXCEL THERAPEUTICS INC's average ROIC has been -437.95%.
- The median ROIC for BIOXCEL THERAPEUTICS INC during this period was -111.45%
- BIOXCEL THERAPEUTICS INC reached its highest ROIC over the past 5 years at -31.19%.
- The lowest ROIC recorded by BIOXCEL THERAPEUTICS INC in the same timeframe -5004.91%
BIOXCEL THERAPEUTICS INC's ROIC vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROIC Benchmarks
Similar metrics to ROIC:
- Cash Return on Invested Capital - [Calculation] Cash Return on Invested Capital (CROIC) measures how well a company uses its invested capital to produce cash. It is calculated as Free Cash Flow [FCF] divided by invested capital [InvCapital].
- Invested Capital - [Calculation] Invested Capital is the total amount of money raised by a business in the form [Equity] and/or [Debt].
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
Definition of Return on Invested Capital
[Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].Net Inc. Cmn. / Inv. Capital
(=) ROIC ROIC for BIOXCEL THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -69.36M ] / Inv. Capital [ $ 222.41M ]
(=) ROIC [ -31.19% ] BTAI - Return on Invested Capital, Last 5 years
-5004.91%
Minimum
Jun 30, 2025
-31.19%
Maximum
Sep 30, 2020
-437.95%
Average
-111.45%
Median
ROIC Benchmark AnalysisMarket
The chart above depicts the distribution of ROIC for companies in the Total Stock Market. The average ROIC of the companies is 0.68% with a standard deviation of 15.2%.
The following table provides additional summary stats:
ROIC in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | -46.36% |
| max | 48.66% |
| average | 0.68% |
| median | 3.38% |
| std | 15.2% |